RE: Bouncebackability23 Sep 2020 15:15
Dadsbatty my point is NCYT has a MKT Cap 4 times that of GDR. They have £20M in cash expected to be around £100M by year end.
Are producing 10.00.000 test per month and rising.
GDR has yet to start producing 1000 test per day in India.
And dont forget the end game for covid testing will be the same for both companies.